Abilitypharma: AbilityPharma raises €1.2M to develop drug for cancer

Spanish biopharmaceutical company AbilityPharma raises €1,233,245, the largest ever on crowdfunding platform Capital Cell, to develop a drug that causes the self-digestion of cancer cells. AbilityPharma surpassed its crowdfunding goal of €1 million set in September, and a total of 377 investors have entered this round with an average ticket of €3,400, according to El Referente. [...]The post AbilityPharma raises €1.2M to develop drug for cancer appeared first on Novobrief.